Literature DB >> 25312947

Expression of enteropathogenic Escherichia coli map is significantly different than that of other type III secreted effectors in vivo.

Mai Nguyen1, Jason Rizvi2, Gail Hecht3.   

Abstract

The enteropathogenic Escherichia coli (EPEC) locus of enterocyte effacement (LEE)-encoded effectors EspF and Map are multifunctional and have an impact on the tight junction barrier while the non-LEE-encoded proteins NleH1 and NleH2 possess significant anti-inflammatory activity. In order to address the temporal expression of these important genes in vivo, their promoters were cloned upstream of the luxCDABE operon, and luciferase expression was measured in EPEC-infected mice by bioluminescence using an in vivo imaging system (IVIS). Bioluminescent images of living mice, of excised whole intestines, and of whole intestines longitudinally opened and washed were assessed. The majority of bioluminescent bacteria localized in the cecum by 3 h postinfection, indicating that the cecum is not only a major colonization site of EPEC but also a site of EPEC effector gene expression in mice. espF, nleH1, and nleH2 were abundantly expressed over the course of infection. In contrast, map expression was suppressed at 2 days postinfection, and at 4 days postinfection it was totally abolished. After 2 to 4 days postinfection, when map is suppressed, EPEC colonization is significantly reduced, indicating that map may be one of the factors required to maintain EPEC colonization. This was confirmed in a competitive colonization study and in two models of chronic infection, repeated exposure to ketamine and Citrobacter rodentium infection. Our data suggest that map expression contributes to the maintenance of EPEC colonization.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25312947      PMCID: PMC4288863          DOI: 10.1128/IAI.02467-14

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  40 in total

1.  Translocated EspF protein from enteropathogenic Escherichia coli disrupts host intestinal barrier function.

Authors:  B P McNamara; A Koutsouris; C B O'Connell; J P Nougayréde; M S Donnenberg; G Hecht
Journal:  J Clin Invest       Date:  2001-03       Impact factor: 14.808

2.  Intestinal barrier dysfunction by enteropathogenic Escherichia coli is mediated by two effector molecules and a bacterial surface protein.

Authors:  Paul Dean; Brendan Kenny
Journal:  Mol Microbiol       Date:  2004-11       Impact factor: 3.501

3.  The enteropathogenic Escherichia coli effector protein EspF decreases sodium hydrogen exchanger 3 activity.

Authors:  Kim Hodges; Neal M Alto; K Ramaswamy; Pradeep K Dudeja; Gail Hecht
Journal:  Cell Microbiol       Date:  2008-04-21       Impact factor: 3.715

4.  Expression of flagella is coincident with uropathogenic Escherichia coli ascension to the upper urinary tract.

Authors:  M Chelsea Lane; Christopher J Alteri; Sara N Smith; Harry L T Mobley
Journal:  Proc Natl Acad Sci U S A       Date:  2007-10-09       Impact factor: 11.205

Review 5.  Enteropathogenic and enterohaemorrhagic Escherichia coli: even more subversive elements.

Authors:  Alexander R C Wong; Jaclyn S Pearson; Michael D Bright; Diana Munera; Keith S Robinson; Sau Fung Lee; Gad Frankel; Elizabeth L Hartland
Journal:  Mol Microbiol       Date:  2011-05-05       Impact factor: 3.501

6.  Enteropathogenic Escherichia coli protein secretion is induced in response to conditions similar to those in the gastrointestinal tract.

Authors:  B Kenny; A Abe; M Stein; B B Finlay
Journal:  Infect Immun       Date:  1997-07       Impact factor: 3.441

7.  The locus of enterocyte effacement-encoded effector proteins all promote enterohemorrhagic Escherichia coli pathogenicity in infant rabbits.

Authors:  Jennifer M Ritchie; Matthew K Waldor
Journal:  Infect Immun       Date:  2005-03       Impact factor: 3.441

8.  Tir phosphorylation and Nck/N-WASP recruitment by enteropathogenic and enterohaemorrhagic Escherichia coli during ex vivo colonization of human intestinal mucosa is different to cell culture models.

Authors:  Stephanie Schüller; Yuwen Chong; Jackie Lewin; Brendan Kenny; Gad Frankel; Alan D Phillips
Journal:  Cell Microbiol       Date:  2007-05       Impact factor: 3.715

9.  Use of stabilized luciferase-expressing plasmids to examine in vivo-induced promoters in the Vibrio cholerae vaccine strain CVD 103-HgR.

Authors:  Cara E Morin; James B Kaper
Journal:  FEMS Immunol Med Microbiol       Date:  2009-07-01

10.  Real-time analysis of effector translocation by the type III secretion system of enteropathogenic Escherichia coli.

Authors:  Erez Mills; Kobi Baruch; Xavier Charpentier; Simi Kobi; Ilan Rosenshine
Journal:  Cell Host Microbe       Date:  2008-02-14       Impact factor: 21.023

View more
  8 in total

1.  The serine protease Pic as a virulence factor of atypical enteropathogenic Escherichia coli.

Authors:  Afonso G Abreu; Cecilia M Abe; Kamila O Nunes; Claudia T P Moraes; Lucia Chavez-Dueñas; Fernando Navarro-Garcia; Angela S Barbosa; Roxane M F Piazza; Waldir P Elias
Journal:  Gut Microbes       Date:  2016-03-10

2.  Let there be bioluminescence: development of a biophotonic imaging platform for in situ analyses of oral biofilms in animal models.

Authors:  Justin Merritt; Hidenobu Senpuku; Jens Kreth
Journal:  Environ Microbiol       Date:  2015-08-05       Impact factor: 5.491

3.  Virulence-Related Genes and Coenteropathogens Associated with Clinical Outcomes of Enteropathogenic Escherichia coli Infections in Children from the Brazilian Semiarid Region: a Case-Control Study of Diarrhea.

Authors:  Ana Karolina S Santos; Pedro Henrique Q S de Medeiros; Mariana D Bona; Mara M G Prata; Marília S M G Amaral; Herlice N Veras; Rafaela C Pankov; Samilly A Ribeiro; Paloma A Cavalcante; Thiago M Freitas; Rafhaella D G Gondim; Daniel M N de Oliveira; Natália K F M Melo; Alexandre Havt; Aldo A M Lima
Journal:  J Clin Microbiol       Date:  2019-03-28       Impact factor: 5.948

Review 4.  Animal Models of Type III Secretion System-Mediated Pathogenesis.

Authors:  Julia A Hotinger; Aaron E May
Journal:  Pathogens       Date:  2019-11-22

Review 5.  Imaging Infection Across Scales of Size: From Whole Animals to Single Molecules.

Authors:  Eric P Skaar
Journal:  Annu Rev Microbiol       Date:  2021-08-03       Impact factor: 16.232

6.  In Vitro Analysis of Predicted DNA-Binding Sites for the Stl Repressor of the Staphylococcus aureus SaPIBov1 Pathogenicity Island.

Authors:  Veronika Papp-Kádár; Judit Eszter Szabó; Kinga Nyíri; Beata G Vertessy
Journal:  PLoS One       Date:  2016-07-07       Impact factor: 3.240

7.  EPEC NleH1 is significantly more effective in reversing colitis and reducing mortality than NleH2 via differential effects on host signaling pathways.

Authors:  Sarah E Kralicek; Mai Nguyen; Ki-Jong Rhee; Rocio Tapia; Gail Hecht
Journal:  Lab Invest       Date:  2018-02-02       Impact factor: 5.662

8.  Mitochondrial Targeting of the Enteropathogenic Escherichia coli Map Triggers Calcium Mobilization, ADAM10-MAP Kinase Signaling, and Host Cell Apoptosis.

Authors:  Rachana Pattani Ramachandran; Chaya Spiegel; Yael Keren; Tsafi Danieli; Naomi Melamed-Book; Ritesh Ranjan Pal; Efrat Zlotkin-Rivkin; Ilan Rosenshine; Benjamin Aroeti
Journal:  mBio       Date:  2020-09-15       Impact factor: 7.867

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.